当前位置:首页 - 行情中心 - 普利制药(300630) - 财务分析 - 资产负债表

普利制药

(300630)

  

流通市值:49.09亿  总市值:65.55亿
流通股本:3.38亿   总股本:4.52亿

资产负债表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
流动资产:
货币资金447,576,764.85391,918,820.38558,387,952.23777,248,693.86
应收票据及应收账款1,391,743,058.061,099,964,814.471,014,589,461.88924,070,859.41
应收账款1,391,743,058.061,099,964,814.471,014,589,461.88924,070,859.41
应收款项融资12,063,259.910,917,942.325,539,411.9390,286,372.02
预付款项279,767,033.54221,542,559.8199,497,540.27177,227,752.88
其他应收款合计20,081,912.1519,385,912.128,566,906.4314,123,710.46
存货403,569,162.68447,523,600.11485,459,996.95322,510,850.58
其他流动资产167,602,772.02162,476,713.77138,066,545.95137,173,368.89
流动资产平衡项目0000
流动资产合计2,722,403,963.22,353,730,362.972,410,563,725.642,443,097,518.1
非流动资产:
长期股权投资--0-
投资性房地产16,762,453.4817,209,037.5517,174,072.2718,158,544.51
固定资产1,303,064,982.471,214,297,626.581,181,009,291.021,177,018,964.59
在建工程1,920,781,765.661,986,842,837.741,936,099,170.751,717,783,412.28
使用权资产4,164,433.584,543,018.434,921,603.285,300,188.13
无形资产272,021,780.45281,917,876.85245,660,374.49203,825,567.68
开发支出398,435,191.71389,107,026.68360,512,205.58351,105,741.45
长期待摊费用7,739,581.497,739,581.498,223,305.338,707,029.17
递延所得税资产41,942,011.0744,293,228.9334,864,280.2434,023,862.06
非流动资产平衡项目0000
非流动资产合计3,964,912,199.913,945,950,234.253,788,464,302.963,515,923,309.87
资产平衡项目0000
资产总计6,687,316,163.116,299,680,597.226,199,028,028.65,959,020,827.97
流动负债:
短期借款361,102,718.49321,086,334.94484,841,770613,389,696.81
应付票据及应付账款424,499,236.46323,034,142.32408,170,408.04401,993,672.05
其中:应付票据143,951,108.72123,020,894.36142,139,699.0490,374,240
应付账款280,548,127.74200,013,247.96266,030,709311,619,432.05
合同负债115,865,102.1799,176,229.32113,140,871.94134,956,550.93
应付职工薪酬11,107,569.8411,051,634.7910,168,395.1516,365,500.74
应交税费100,756,225.9661,160,845.8631,308,939.8578,265,815.85
其他应付款合计16,216,378.2266,989,698.6232,420,373.4634,956,507.06
应付股利-34,116,090.6--
一年内到期的非流动负债366,484,790.8543,055,333.55153,549,000187,410,839.57
其他流动负债15,062,463.2812,892,909.814,708,313.3516,759,461.09
流动负债平衡项目0000
流动负债合计1,411,094,485.27938,447,129.21,248,308,071.791,484,098,044.1
非流动负债:
长期借款1,071,149,906.541,332,441,228.75999,238,137.82689,214,991.96
应付债券828,906,447.86814,564,669.73805,968,248.7791,829,903.79
租赁负债3,020,8743,914,617.735,450,247.734,691,012.17
递延收益161,056,150.67138,705,708.14129,873,898.94116,981,373.08
递延所得税负债69,694,871.7358,478,207.0769,694,871.7369,694,871.73
非流动负债平衡项目0000
非流动负债合计2,133,828,250.82,348,104,431.422,010,225,404.921,672,412,152.73
负债平衡项目0000
负债合计3,544,922,736.073,286,551,560.623,258,533,476.713,156,510,196.83
所有者权益(或股东权益):
实收资本(或股本)436,352,572436,352,572436,352,407436,352,407
其他权益工具118,935,743.07118,935,743.07118,936,434.81118,936,434.81
资本公积656,556,113.01656,556,113.01656,552,078.01656,552,078.01
减:库存股96,735,338.9191,703,205.9166,705,218.9566,705,218.95
专项储备1,626,159.761,684,376.691,451,796.221,900,961.88
盈余公积191,562,903.1191,562,903.1191,562,903.1191,562,903.1
未分配利润1,834,095,275.011,699,740,534.641,602,344,151.71,463,911,065.29
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计3,142,393,427.043,013,129,036.62,940,494,551.892,802,510,631.14
股东权益平衡项目0000
股东权益合计3,142,393,427.043,013,129,036.62,940,494,551.892,802,510,631.14
负债和股东权益合计6,687,316,163.116,299,680,597.226,199,028,028.65,959,020,827.97
公告日期2023-10-252023-08-252023-04-252023-04-25
审计意见(境内)标准无保留意见
TOP↑